The Icahn School of Medicine at Mount Sinai was awarded a $1,014,000 federal Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant is for the project "CREATING CURES FOR PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS", with a period of performance from September 1, 2024 to August 31, 2028. The award will support the medical institution's specialized research and development activities aimed at advancing treatments for Langerhans cell histiocytosis, a rare condition affecting the immune system. As a renowned academic medical center, the Icahn School of Medicine at Mount Sinai will leverage its expertise in areas such as genomics, immunology, and clinical research to conduct innovative studies that seek to improve health outcomes for military service members and the broader public.
Generated 3/18/25, 1:50 AM